368 related articles for article (PubMed ID: 29676827)
41. In vivo imaging of acute physiological responses after treatment of cancer with near-infrared photoimmunotherapy.
Nakajima K; Sugikawa A; Yasui H; Higashikawa K; Suzuki C; Natsume T; Suzuki M; Takakura H; Tomita M; Takahashi S; Hirata K; Magata Y; Kuge Y; Ogawa M
Mol Imaging Biol; 2023 Aug; 25(4):648-658. PubMed ID: 37193805
[TBL] [Abstract][Full Text] [Related]
42. HER2 targeting near-infrared photoimmunotherapy for a CDDP-resistant small-cell lung cancer.
Takahashi K; Taki S; Yasui H; Nishinaga Y; Isobe Y; Matsui T; Shimizu M; Koike C; Sato K
Cancer Med; 2021 Dec; 10(24):8808-8819. PubMed ID: 34729945
[TBL] [Abstract][Full Text] [Related]
43. Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers.
Cui Y; Xu Y; Li Y; Sun Y; Hu J; Jia J; Li X
Technol Cancer Res Treat; 2023; 22():15330338221145992. PubMed ID: 36734039
[TBL] [Abstract][Full Text] [Related]
44. Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer.
Isobe Y; Sato K; Nishinaga Y; Takahashi K; Taki S; Yasui H; Shimizu M; Endo R; Koike C; Kuramoto N; Yukawa H; Nakamura S; Fukui T; Kawaguchi K; Chen-Yoshikawa TF; Baba Y; Hasegawa Y
EBioMedicine; 2020 Feb; 52():102632. PubMed ID: 31981983
[TBL] [Abstract][Full Text] [Related]
45. A Novel Theranostic Combination of Near-infrared Fluorescence Imaging and Laser Irradiation Targeting c-KIT for Gastrointestinal Stromal Tumors.
Fujimoto S; Muguruma N; Okamoto K; Kurihara T; Sato Y; Miyamoto Y; Kitamura S; Miyamoto H; Taguchi T; Tsuneyama K; Takayama T
Theranostics; 2018; 8(9):2313-2328. PubMed ID: 29721082
[TBL] [Abstract][Full Text] [Related]
46. Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.
Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Fujimura D; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H
Cancer Immunol Immunother; 2022 Aug; 71(8):1877-1887. PubMed ID: 35013765
[TBL] [Abstract][Full Text] [Related]
47. Real-time monitoring of microdistribution of antibody-photon absorber conjugates during photoimmunotherapy in vivo.
Tang Q; Nagaya T; Liu Y; Lin J; Sato K; Kobayashi H; Chen Y
J Control Release; 2017 Aug; 260():154-163. PubMed ID: 28601576
[TBL] [Abstract][Full Text] [Related]
48. Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer.
Katsube R; Noma K; Ohara T; Nishiwaki N; Kobayashi T; Komoto S; Sato H; Kashima H; Kato T; Kikuchi S; Tazawa H; Kagawa S; Shirakawa Y; Kobayashi H; Fujiwara T
Sci Rep; 2021 Jan; 11(1):1693. PubMed ID: 33462372
[TBL] [Abstract][Full Text] [Related]
49. Wound healing after excision of subcutaneous tumors treated with near-infrared photoimmunotherapy.
Rosenberg A; Inagaki F; Kato T; Okada R; Wakiyama H; Furusawa A; Choyke PL; Kobayashi H
Cancer Med; 2020 Aug; 9(16):5932-5939. PubMed ID: 32579795
[TBL] [Abstract][Full Text] [Related]
50. Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT).
Siddiqui MR; Railkar R; Sanford T; Crooks DR; Eckhaus MA; Haines D; Choyke PL; Kobayashi H; Agarwal PK
Sci Rep; 2019 Feb; 9(1):2084. PubMed ID: 30765854
[TBL] [Abstract][Full Text] [Related]
51. Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases.
Inagaki FF; Wakiyama H; Furusawa A; Okada R; Kato T; Fujimura D; Okuyama S; Fukushima H; Takao S; Choyke PL; Kobayashi H
Biomed Pharmacother; 2023 Apr; 160():114390. PubMed ID: 36791566
[TBL] [Abstract][Full Text] [Related]
52. Near-Infrared Photoimmunotherapy of Cancer.
Kobayashi H; Choyke PL
Acc Chem Res; 2019 Aug; 52(8):2332-2339. PubMed ID: 31335117
[TBL] [Abstract][Full Text] [Related]
53. Molecular imaging of tumor photoimmunotherapy: Evidence of photosensitized tumor necrosis and hemodynamic changes.
Kishimoto S; Oshima N; Yamamoto K; Munasinghe J; Ardenkjaer-Larsen JH; Mitchell JB; Choyke PL; Krishna MC
Free Radic Biol Med; 2018 Feb; 116():1-10. PubMed ID: 29289705
[TBL] [Abstract][Full Text] [Related]
54. Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti-CD44-Based NIR-PIT.
Nagaya T; Nakamura Y; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Allen C; Kobayashi H
Mol Cancer Res; 2017 Dec; 15(12):1667-1677. PubMed ID: 28923838
[TBL] [Abstract][Full Text] [Related]
55. Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody.
Nagaya T; Okuyama S; Ogata F; Maruoka Y; Knapp DW; Karagiannis SN; Fazekas-Singer J; Choyke PL; LeBlanc AK; Jensen-Jarolim E; Kobayashi H
Oncotarget; 2018 Apr; 9(27):19026-19038. PubMed ID: 29721181
[TBL] [Abstract][Full Text] [Related]
56. The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near-Infrared Photoimmunotherapy.
Okada R; Maruoka Y; Furusawa A; Inagaki F; Nagaya T; Fujimura D; Choyke PL; Kobayashi H
Bioconjug Chem; 2019 Oct; 30(10):2624-2633. PubMed ID: 31498995
[TBL] [Abstract][Full Text] [Related]
57. Quantitative Assessment of the Efficacy of Near-Infrared Photoimmunotherapy with Bioluminescence Imaging.
Okada R; Furusawa A; Choyke PL; Kobayashi H
Methods Mol Biol; 2022; 2525():3-13. PubMed ID: 35836056
[TBL] [Abstract][Full Text] [Related]
58. [Near Infrared Photoimmunotherapy for Cancer].
Kobayashi H
Gan To Kagaku Ryoho; 2019 Jan; 46(1):28-33. PubMed ID: 30765637
[TBL] [Abstract][Full Text] [Related]
59. Hurdles for the wide implementation of photoimmunotherapy.
Matsuoka K; Sato M; Sato K
Immunotherapy; 2021 Dec; 13(17):1427-1438. PubMed ID: 34693721
[TBL] [Abstract][Full Text] [Related]
60. MRP1-targeted near infrared photoimmunotherapy for drug resistant small cell lung cancer.
Li F; Mao C; Yeh S; Sun Y; Xin J; Shi Q; Ming X
Int J Pharm; 2021 Jul; 604():120760. PubMed ID: 34077781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
